Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment

Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment

Introduction: Papillary thyroid cancer (PTC) is the most common endocrine malignancy. More than 98% of patients achieve an excellent response with no evidence of clinical, biochemical, or structural disease after initial treatment. In these patients structural recurrence is rare, more frequently dia...

Full description

Bibliographic Details
Main Authors: David Viola, Laura Agate, Eleonora Molinaro, Valeria Bottici, Loredana Lorusso, Francesco Latrofa, Liborio Torregrossa, Laura Boldrini, Teresa Ramone, Paolo Vitti, Rossella Elisei
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-10-01
Series:Frontiers in Endocrinology
Subjects:
thyroid cancer (TC)
TgAb
recurrence
BRAF mutation
lymphocytic thyroiditis
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2018.00590/full

Similar Items

Similar Items